IN2013MU02045A - - Google Patents

Download PDF

Info

Publication number
IN2013MU02045A
IN2013MU02045A IN2045MU2013A IN2013MU02045A IN 2013MU02045 A IN2013MU02045 A IN 2013MU02045A IN 2045MU2013 A IN2045MU2013 A IN 2045MU2013A IN 2013MU02045 A IN2013MU02045 A IN 2013MU02045A
Authority
IN
India
Prior art keywords
mscs
relates
treating
type
diabetes
Prior art date
Application number
Other languages
English (en)
Inventor
Satish Mahadeorao Totey
Lyle Carl Fonseca
Manoj Kumar C Reddy
Shashank Gowda
Aarya HARI
Basavaraj Chougule
Minita Sodhi
Sneha Deepak Laghate
Nicole Rachel Koshy
Original Assignee
Kasiak Res Pvt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kasiak Res Pvt Ltd filed Critical Kasiak Res Pvt Ltd
Priority to PCT/IN2013/000582 priority Critical patent/WO2014203267A2/en
Priority to IN2045MU2013 priority patent/IN2013MU02045A/en
Publication of IN2013MU02045A publication Critical patent/IN2013MU02045A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IN2045MU2013 2013-06-17 2013-09-26 IN2013MU02045A (https=)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/IN2013/000582 WO2014203267A2 (en) 2013-06-17 2013-09-26 Method for isolation, purification and industrial scale expansion of human adipose tissue derived mesenchymal stem cells
IN2045MU2013 IN2013MU02045A (https=) 2013-06-17 2013-09-26

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2045MU2013 IN2013MU02045A (https=) 2013-06-17 2013-09-26

Publications (1)

Publication Number Publication Date
IN2013MU02045A true IN2013MU02045A (https=) 2015-06-05

Family

ID=52105422

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2045MU2013 IN2013MU02045A (https=) 2013-06-17 2013-09-26

Country Status (2)

Country Link
IN (1) IN2013MU02045A (https=)
WO (1) WO2014203267A2 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR20150100378A (el) * 2015-08-25 2017-04-10 Βαλερι-Σεσιλ-Αννα Παντελη Αγγελου Μεθοδος απομονωσης μεσεγχυματικων βλαστικων κυτταρων εκ λιπωδους ιστου
JP6998768B2 (ja) 2015-08-28 2022-02-10 ロート製薬株式会社 Ｒｏｒ１陽性の間葉系幹細胞及びその調製方法、ｒｏｒ１陽性の間葉系幹細胞を含む医薬組成物及びその調製方法、並びにｒｏｒ１陽性の間葉系幹細胞を用いる疾患の予防又は治療方法
JP2018531269A (ja) * 2015-10-23 2018-10-25 リグスホスピタレットＲｉｇｓｈｏｓｐｉｔａｌｅｔ 脂肪由来幹細胞に基づく幹細胞治療
CN118406643A (zh) 2016-11-11 2024-07-30 美商生命科学有限公司 使用人类间充质干细胞以实现细胞免疫及体液免疫的方法
CN110139657A (zh) * 2017-02-15 2019-08-16 日本乐敦制药株式会社 肺纤维化治疗剂、ptprr表达促进剂及肺纤维化治疗用试剂盒
US20200069740A1 (en) * 2017-03-08 2020-03-05 Rohto Pharmaceutical Co., Ltd. Ror1-positive mesenchymal stem cell-containing pharmaceutical composition for preventing or treating disease associated with fibrosis, method for preparing same, and method for preventing or treating disease associated with fibrosis using ror1-positive mesenchymal stem cells
WO2019175773A1 (en) 2018-03-12 2019-09-19 Universidade Do Porto Compositions for use in the treatment of musculoskeletal conditions and methods for producing the same leveraging the synergistic activity of two different types of mesenchymal stromal/stem cells
WO2020165404A1 (en) 2019-02-15 2020-08-20 Rigshospitalet Stem cell therapy for lacrimal gland dysfunction
WO2020165405A1 (en) 2019-02-15 2020-08-20 Rigshospitalet Stem cell therapy for patients with salivary gland dysfunction
CN111514164A (zh) * 2020-04-30 2020-08-11 深圳市合一康生物科技股份有限公司 一种用于肺病治疗的脂肪间充质干细胞及其制备方法
EP3909593A1 (en) 2020-05-15 2021-11-17 Rigshospitalet Stem cells for treating skin lesions
WO2022115696A2 (en) * 2020-11-30 2022-06-02 Chan Zuckerberg Biohub, Inc. Reconstitution of a split-halotag via orthogonal tag-binding domains
CN112646030B (zh) * 2021-01-11 2021-11-30 内蒙古创润生物科技有限公司 一种包含间充质干细胞外泌体的药物组合物在治疗疾病中的应用
HU231475B1 (hu) * 2021-04-01 2024-02-28 Cellfactory Korlátolt Felelősségű Társaság Eljárás osteoartritisben szenvedő egyed kezelésére szolgáló készítmény előállítására
EP4405462A1 (en) * 2021-09-23 2024-07-31 Aarhus Universitet Ready-to-use stem cell therapeutic

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2669368B1 (en) * 2006-05-17 2016-08-03 Cognate Therapeutics, Inc. Isolation and purification of hematopoietic stem cells from post-liposuction lipoaspirates
US8808688B2 (en) * 2009-10-06 2014-08-19 National University Corporation Nagoya University Cell preparation for erectile dysfunction or sensory disorders of the lower urinary tract containing adipose tissue derived mesenchymal stem cells
WO2011064733A1 (en) * 2009-11-27 2011-06-03 Stempeutics Research Pvt. Ltd. Methods of preparing mesenchymal stem cells, compositions and kit thereof
EP2333047A1 (en) * 2009-12-09 2011-06-15 Fresenius Medical Care Deutschland GmbH Adult stem cell derived conditioned medium and/or adult stem cells for use in the therapeutic treatment of a tumor disease
CA2788635A1 (en) * 2010-02-01 2011-08-04 The Board Of Trustees Of The Leland Stanford Junior University Enhanced efficiency of induced pluripotent stem cell generation
US20130129688A1 (en) * 2011-11-09 2013-05-23 Allocure, Inc. Assay for the Prediction of Therapeutic Effectiveness or Potency of Mesenchymal Stem Cells, and Methods of Using Same

Also Published As

Publication number Publication date
WO2014203267A3 (en) 2015-03-26
WO2014203267A2 (en) 2014-12-24

Similar Documents

Publication Publication Date Title
IN2013MU02045A (https=)
IN2013MU02046A (https=)
BR112018004377A2 (pt) cepas de levedura para a expressão e secreção de proteínas heterólogas em temperaturas elevadas
ECSP17039547A (es) Nuevas normalizaciones y dispositivos médicos para la preparación de plasma rico en plaquetas (prp) o concentrado de médula ósea (bmc) solos o combinados con ácido hialurónico
MY195318A (en) Multispecific Antibody Constructs
IN2015KN00262A (https=)
MY186892A (en) Utilizing a multiphase reactor for the conversion of biomass to produce substituted furans
MX2015015312A (es) Proceso para la sintesis de 5-hidroximetilfurfural a partir de sacaridos.
MX2015015188A (es) Metodo de clonacion, expresion y purificacion novedoso para la preparacion de ranibizumab.
MX2016006755A (es) Toalla suave y voluminosa.
PH12016501777A1 (en) Novel lactobacillus paracasei strain
UA109575C2 (uk) Спосіб термічної стерилізації медичного контейнера
IN2014DE02492A (https=)
MY189932A (en) Recombinant microorganism for improved production of alanine
EA201691754A1 (ru) Рекомбинантный микроорганизм, экспрессирующий аналог авермектина, и его применение
MY174468A (en) Bio-based arcylic acid and its derivatives
CO6430457A2 (es) Proceso para la preparación de amidas del ácido pirazol carboxilico
PH12013501951A1 (en) Agent for improving or maintaining qol
IN2013MU02047A (https=)
WO2015057836A3 (en) Bone anabolic parathyroid hormone and parathyroid hormone related-protein analogs
MY186559A (en) O-acetylhomoserine sulfhydrylase variant and method for producing l-methionine using same
MY174840A (en) Microorganism producing o-acetyl-homoserine, and method for producing o-acetyl-homoserine by using same
NZ700842A (en) Frozen noodles and production method therefor
BR112016026885A8 (pt) processo para desidratação contínua de ácido 3-hidroxipropanoico aquoso em ácido acrílico
AR099951A1 (es) Proceso para preparar eteno